One of the studies done with Wegovy showed that people lost 15% of their body mass in a year, but they also eat 500 Calories less and exercised for 2.5 hours a week.
At the present time, Ozempic is not approved for Type 1 diabetes:
>...Ozempic® is not for use in people with type 1 diabetes.
Compared with Type 2, with Type 1 diabetes there are other risks that could occur:
>...While medications such as GLP-1 receptor agonists (Ozempic, Wegovy) and SGLT-2 inhibitors (Jardiance, Farxiga) demonstrated powerful benefits, they quickly were determined to pose too much of a liability for pharmaceutical companies or regulators due to concerns about safety. Specifically, GLP-1s can increase the risk of hypoglycemia (low blood sugar) and SGLT-2s can raise the risk of a serious, life-threatening complication called diabetic ketoacidosis (DKA).
https://diatribe.org/diabetes-medications/why-diabetes-mirac...
Misinformation is also going to be much overused and meaningless if used for situations like a simple mistake. The commenter just misread something - branding it as misinformation seems to imply intent, otherwise why wouldn't you just call it a mistake?
The point was that the 15% weight lose in a year is in the high end of what you can expect, especially if you change nothing else.
This is especially true if you count light exercise.
Maybe there is a path to using these drugs in a manner to get people healthier so they can exercise more, establish good habits and taper down.